Pulmatrix Inc. [NASDAQ: PULM] loss -9.48% or -0.2 points to close at $1.91 with a heavy trading volume of 6525026 shares. The company report on February 16, 2021 that Pulmatrix Announces Closing of $40 Million Registered Direct Offering.
Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, announced that it has closed its previously announced registered direct offering with certain healthcare-focused institutional investors for the sale of 20,000,000 shares of its common stock for gross proceeds of $40,000,000, prior to deducting placement agent’s fees and other offering expenses.
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
It opened the trading session at $2.10, the shares rose to $2.1194 and dropped to $1.83, the range by which the price of stock traded the whole day. The daily chart for PULM points out that the company has recorded 50.39% gains over the past six months. However, it is still -112.22% lower than its most recent low trading price.
If we look at the average trading volume of 1.58M shares, PULM reached to a volume of 6525026 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Pulmatrix Inc. [PULM]:
H.C. Wainwright have made an estimate for Pulmatrix Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 09, 2018.
The Average True Range (ATR) for Pulmatrix Inc. is set at 0.24, with the Price to Sales ratio for PULM stock in the period of the last 12 months amounting to 5.32. The Price to Book ratio for the last quarter was 2.77, with the Price to Cash per share for the same quarter was set at 1.01.
Trading performance analysis for PULM stock
Pulmatrix Inc. [PULM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.02. With this latest performance, PULM shares gained by 50.39% in over the last four-week period, additionally plugging by 50.39% over the last 6 months – not to mention a rise of 15.76% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PULM stock in for the last two-week period is set at 55.97, with the RSI for the last a single of trading hit 53.50, and the three-weeks RSI is set at 57.05 for Pulmatrix Inc. [PULM]. The present Moving Average for the last 50 days of trading for this stock 1.4536, while it was recorded at 2.1400 for the last single week of trading, and 1.3772 for the last 200 days.
Pulmatrix Inc. [PULM]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Pulmatrix Inc. [PULM] shares currently have an operating margin of -169.71. Pulmatrix Inc.’s Net Margin is presently recorded at -260.38.
Return on Total Capital for PULM is now -114.06, given the latest momentum, and Return on Invested Capital for the company is -180.17. Return on Equity for this stock declined to -180.17, with Return on Assets sitting at -81.05. When it comes to the capital structure of this company, Pulmatrix Inc. [PULM] has a Total Debt to Total Equity ratio set at 6.13. Additionally, PULM Total Debt to Total Capital is recorded at 5.77, with Total Debt to Total Assets ending up at 1.87.
Reflecting on the efficiency of the workforce at the company, Pulmatrix Inc. [PULM] managed to generate an average of -$936,182 per employee. Receivables Turnover for the company is 2.20 with a Total Asset Turnover recorded at a value of 0.31.Pulmatrix Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.50 and a Current Ratio set at 3.50.
Pulmatrix Inc. [PULM]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Pulmatrix Inc. posted -0.16/share EPS, while the average EPS was predicted by analysts to be reported at -0.27/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 40.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PULM.
An analysis of insider ownership at Pulmatrix Inc. [PULM]
There are presently around $16 million, or 32.70% of PULM stock, in the hands of institutional investors. The top three institutional holders of PULM stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 2,572,542, which is approximately 29.016% of the company’s market cap and around 1.09% of the total institutional ownership; SABBY MANAGEMENT, LLC, holding 1,975,309 shares of the stock with an approximate value of $3.77 million in PULM stocks shares; and VANGUARD GROUP INC, currently with $3.01 million in PULM stock with ownership of nearly -1.553% of the company’s market capitalization.
Positions in Pulmatrix Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 10 institutional holders increased their position in Pulmatrix Inc. [NASDAQ:PULM] by around 935,243 shares. Additionally, 13 investors decreased positions by around 327,499 shares, while 6 investors held positions by with 6,868,241 shares. The mentioned changes placed institutional holdings at 8,130,983 shares, according to the latest SEC report filing. PULM stock had 3 new institutional investments in for a total of 57,965 shares, while 5 institutional investors sold positions of 155,659 shares during the same period.